nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis
|
Wang, Min |
|
|
207 |
C |
p. |
artikel |
2 |
A review of KLF4 and inflammatory disease: Current status and future perspective
|
Liang, Yidan |
|
|
207 |
C |
p. |
artikel |
3 |
Bugs as drugs: Extended clinical applications and potential translational trends of Akkermansia muciniphila in oncology and comprehensive clinical investigation panorama of therapeutic microbiome modulators in gastric cancer treatment
|
Wang, Yuning |
|
|
207 |
C |
p. |
artikel |
4 |
Busting myths, biting facts: Unraveling the link between Porphyromonas and pancreatic cancer risk
|
Luo, Yalan |
|
|
207 |
C |
p. |
artikel |
5 |
CD31 orchestrates metabolic regulation in autophagy pathways of rheumatoid arthritis
|
Cheung, Kenneth CP |
|
|
207 |
C |
p. |
artikel |
6 |
Comprehensive analysis of therapeutic strategies for Gouty nephropathy: Insights from clinical trials
|
Li, Jianing |
|
|
207 |
C |
p. |
artikel |
7 |
Corrigendum to “α-Lipoic acid prevents senescence, cell cycle arrest, and inflammatory cues in fibroblasts by inhibiting oxidative stress” [Pharmacol. Res. 141 (2019) 214–223]
|
Baeeri, Maryam |
|
|
207 |
C |
p. |
artikel |
8 |
Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance
|
Benfield, Aurélie H. |
|
|
207 |
C |
p. |
artikel |
9 |
Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia
|
Lu, Yawen |
|
|
207 |
C |
p. |
artikel |
10 |
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
|
Zhang, Yanyan |
|
|
207 |
C |
p. |
artikel |
11 |
Editorial Board
|
|
|
|
207 |
C |
p. |
artikel |
12 |
Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
|
Cao, Chunhao |
|
|
207 |
C |
p. |
artikel |
13 |
“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression
|
Yin, Yishu |
|
|
207 |
C |
p. |
artikel |
14 |
Inhibition of K63 ubiquitination by G-Protein pathway suppressor 2 (GPS2) regulates mitochondria-associated translation
|
Gao, Yuan |
|
|
207 |
C |
p. |
artikel |
15 |
Insight into endothelial cell-derived extracellular vesicles in cardiovascular disease: Molecular mechanisms and clinical implications
|
Wang, Xia |
|
|
207 |
C |
p. |
artikel |
16 |
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
|
Bruns VI, Nicolaus |
|
|
207 |
C |
p. |
artikel |
17 |
Leo Sternbach and the benzodiazepines 60 years on: A revolutionary treatment for anxiety disorders
|
Junkes, Larissa |
|
|
207 |
C |
p. |
artikel |
18 |
Microbiota alterations associated with vascular diseases: postbiotics as a next-generation magic bullet for gut-vascular axis
|
Flori, Lorenzo |
|
|
207 |
C |
p. |
artikel |
19 |
Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis
|
Caspani, Giorgia |
|
|
207 |
C |
p. |
artikel |
20 |
Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury
|
Ye, Yufei |
|
|
207 |
C |
p. |
artikel |
21 |
Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions
|
Li, Cuiping |
|
|
207 |
C |
p. |
artikel |
22 |
Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
|
Chen, Ting |
|
|
207 |
C |
p. |
artikel |
23 |
Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma
|
Liu, Dajia |
|
|
207 |
C |
p. |
artikel |
24 |
Regulation mechanism of endoplasmic reticulum stress on metabolic enzymes in liver diseases
|
Zhou, Shaojun |
|
|
207 |
C |
p. |
artikel |
25 |
Silencing of tropomodulin 1 inhibits acute myeloid leukemia cell proliferation and tumor growth by elevating karyopherin alpha 2–mediated autophagy
|
Xia, Yuan |
|
|
207 |
C |
p. |
artikel |
26 |
Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer
|
Tan, Yan |
|
|
207 |
C |
p. |
artikel |
27 |
The brain-protective mechanism of fecal microbiota transplantation from young donor mice in the natural aging process via exosome, gut microbiota, and metabolomics analyses
|
Lin, Longfei |
|
|
207 |
C |
p. |
artikel |
28 |
The current status and future trends of BTK inhibitor for diffuse large B cell lymphoma
|
Chen, Qiuni |
|
|
207 |
C |
p. |
artikel |
29 |
The dual role of NSD2 in mitochondrial function: Insights into interstitial fibrosis and renal cancer
|
Huang, Chien-Wei |
|
|
207 |
C |
p. |
artikel |
30 |
The role of amino acid metabolism alterations in acute ischemic stroke: From mechanism to application
|
Wang, Xiang-Ping |
|
|
207 |
C |
p. |
artikel |
31 |
The role of polyphenols in modulating mitophagy: Implications for therapeutic interventions
|
Lin, Xinyu |
|
|
207 |
C |
p. |
artikel |
32 |
Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy
|
Liu, Li |
|
|
207 |
C |
p. |
artikel |